Breaking News, Promotions & Moves

Dragonfly Therapeutics Taps Susan Altschuller as CFO

Altschuller boasts more than two decades of strategic and financial leadership experience at leading pharmaceutical and biotechnology companies.

Author Image

By: Charlie Sternberg

Associate Editor

Dragonfly Therapeutics Inc. has expanded its executive leadership team with the addition of Dr. Susan Altschuller as Chief Financial Officer. About Susan Altschuller Ph.D., MBA Altschuller is a seasoned executive with more than two decades of strategic and financial leadership experience at leading pharmaceutical and biotechnology companies. Most recently, she served as the chief financial officer of Cerevel Therapeutics, a biotechnology company developing therapies for neuroscience disease...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters